can you take glp 1 after thyroidectomy GLP-1 Receptor Agonists and Thyroid Cancer Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid Implications of GLP-1 Receptor Agonist

They are injected into fatty tissue in the body and often contain phentermine as well as vitamin B12

Be sure to consult with your healthcare provider before restarting treatment, as dosage adjustments may be necessary

Current research does not show that BPC-157 directly causes weight loss

BPC-157 is not commonly associated with significant weight gain or water retention

While it can contribute to weight loss, its not officially approved for it

GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months